You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 22, 2025

Details for Patent: 10,435,692


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,435,692 protect, and when does it expire?

Patent 10,435,692 protects OXLUMO and is included in one NDA.

This patent has thirty patent family members in eighteen countries.

Summary for Patent: 10,435,692
Title:Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
Abstract: This invention relates to compounds, compositions, and methods useful for reducing Glycolate Oxidase (HAO1) target RNA and protein levels via use of dsRNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.
Inventor(s): Brown; Bob D. (Littleton, MA), Dudek; Henryk T. (Wellesley, MA)
Assignee: Dicerna Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:15/793,441
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of United States Patent 10,435,692

Introduction

When analyzing a U.S. patent, it is crucial to understand the scope and claims of the patent, as these elements define the inventor's exclusive rights and the boundaries of the invention. This article will provide a comprehensive guide on how to analyze the scope and claims of a patent, using United States Patent 10,435,692 as an example.

What is a Patent?

A patent is a form of intellectual property that grants the inventor the exclusive right to make, use, or sell their invention for a specified period, typically 20 years from the filing date. Patents are granted by the United States Patent and Trademark Office (USPTO) and are defined by the claims, which are the legal descriptions of the invention[4].

Finding and Accessing Patent Information

To analyze a patent, you first need to find and access the patent documentation. The USPTO provides several tools for this purpose, including the Public Search Facility and online databases. The Global Dossier service, for instance, allows users to view the file histories of related applications from participating IP Offices, including the IP5 Offices[1].

Understanding Patent Claims

Patent claims are the heart of a patent application and define the scope of the invention. There are two main types of claims: independent claims and dependent claims.

Independent Claims

Independent claims stand alone and define the invention without reference to other claims. They are typically broader and more general. For example, if a patent has multiple independent claims, each claim might cover a different aspect of the invention[3].

Dependent Claims

Dependent claims refer back to and further limit an independent claim. They are narrower and more specific, often detailing particular embodiments or variations of the invention.

Analyzing the Scope of Patent Claims

The scope of patent claims is a critical aspect of patent analysis. Here are some metrics and considerations:

Claim Length and Count

Research has shown that the length and count of independent claims can be simple yet effective metrics for measuring patent scope. Longer and more numerous independent claims often indicate broader patents, which can have implications for patent quality and the examination process[3].

Forward Citations and Patent Maintenance

The number of forward citations (citations by later patents) and patent maintenance payments can also indicate the scope and importance of a patent. Patents with more forward citations and higher maintenance payments tend to have a broader scope and greater impact[3].

Patent Eligibility and Subject Matter

Patent eligibility under 35 U.S.C. § 101 is another crucial aspect. The Supreme Court has established that laws of nature, natural phenomena, and abstract ideas are not patentable. The two-stage framework set by the Supreme Court in cases like Alice Corp. v. CLS Bank Int’l helps determine whether a claim is eligible for patenting[5].

Case Study: United States Patent 10,435,692

To illustrate these concepts, let's consider a hypothetical analysis of United States Patent 10,435,692, though the specific details of this patent are not provided here.

Identifying the Patent

First, locate the patent using the USPTO's public search facilities or online databases. The patent number, 10,435,692, can be used to find the full text of the patent.

Reading the Claims

Carefully read the claims section of the patent. Identify the independent claims and dependent claims. Analyze each claim to understand what aspects of the invention it covers.

Understanding the Scope

Determine the scope of the claims by looking at their breadth and specificity. Use metrics such as claim length and count to gauge the overall scope of the patent.

Checking Patent Eligibility

Ensure that the claims do not fall under the exceptions outlined in 35 U.S.C. § 101. Check if the claims describe a new and useful process, machine, manufacture, or composition of matter, or an improvement thereof.

Reviewing Forward Citations and Maintenance

Look up forward citations to see how often the patent is cited by later patents. This can indicate the patent's influence and scope. Also, check the patent maintenance payments to see if the patent holder is continuing to pay to keep the patent in force.

Patent Landscape Analysis

Understanding the broader patent landscape is essential for contextualizing a specific patent.

Technology Areas

The USPTO classifies patents into various technology areas based on the World Intellectual Property Organization (WIPO) classification. Analyze the technology area in which the patent is classified to understand the trends and focus of patenting in that field[4].

Patent Families

A patent family includes all related patents filed in different jurisdictions that have a common original invention. Analyzing the patent family can provide insights into the global reach and variations of the invention[4].

Comparative Global Trends

Compare the patenting trends in the U.S. with global trends. This can help in understanding the international impact and relevance of the invention[4].

Key Takeaways

  • Patent Claims: The claims section is the most critical part of a patent, defining the scope of the invention.
  • Scope Analysis: Use metrics like claim length and count, forward citations, and patent maintenance payments to gauge the scope.
  • Patent Eligibility: Ensure claims comply with 35 U.S.C. § 101 and do not cover abstract ideas, laws of nature, or natural phenomena.
  • Patent Landscape: Analyze the technology area, patent family, and global trends to understand the broader context.

FAQs

Q: How do I find a specific U.S. patent?

A: You can find a specific U.S. patent by using the USPTO's public search facilities or online databases, such as the Global Dossier service[1].

Q: What is the difference between independent and dependent claims?

A: Independent claims stand alone and define the invention broadly, while dependent claims refer back to and further limit an independent claim, making them narrower and more specific[3].

Q: How do I determine if a patent claim is eligible under 35 U.S.C. § 101?

A: Use the two-stage framework established by the Supreme Court to determine if the claim covers abstract ideas, laws of nature, or natural phenomena, and if it provides an inventive step beyond conventional technology[5].

Q: What is the significance of forward citations in patent analysis?

A: Forward citations indicate how often a patent is cited by later patents, which can reflect the patent's influence and scope within the field[3].

Q: How do patent families help in understanding a patent?

A: Patent families show all related patents filed in different jurisdictions, providing insights into the global reach and variations of the invention[4].

Sources

  1. USPTO: Search for patents - USPTO. Retrieved from https://www.uspto.gov/patents/search
  2. ACUS: U.S. Patent Small Claims Court. Retrieved from https://www.acus.gov/research-projects/us-patent-small-claims-court
  3. SSRN: Patent Claims and Patent Scope. Retrieved from https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. NCSES: Invention: U.S. and Comparative Global Trends. Retrieved from https://ncses.nsf.gov/pubs/nsb20204/invention-u-s-and-comparative-global-trends
  5. CAFC: Electric Power Group, LLC v. Alstom S.A. Retrieved from https://cafc.uscourts.gov/opinions-orders/15-1778.opinion.7-28-2016.1.pdf

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,435,692

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Alnylam Pharms Inc OXLUMO lumasiran sodium SOLUTION;SUBCUTANEOUS 214103-001 Nov 23, 2020 RX Yes Yes 10,435,692 ⤷  Try for Free TREATMENT OF PRIMARY HYPEROXALURIA TYPE 1 (PH1) ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,435,692

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3581654 ⤷  Try for Free LUC00218 Luxembourg ⤷  Try for Free
European Patent Office 3581654 ⤷  Try for Free PA2021008 Lithuania ⤷  Try for Free
European Patent Office 3581654 ⤷  Try for Free 301132 Netherlands ⤷  Try for Free
European Patent Office 3581654 ⤷  Try for Free 2021C/534 Belgium ⤷  Try for Free
European Patent Office 3581654 ⤷  Try for Free CA 2021 00038 Denmark ⤷  Try for Free
European Patent Office 3581654 ⤷  Try for Free 122021000053 Germany ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.